Ureteral obstruction secondary to indinavir in the pediatric HIV population

Indinavir sulfate is a protease inhibitor used in the treatment of the human immunodeficiency virus (HIV). This case report describes the radiographic and urologic manifestations of indinavir urolithiasis in two pediatric patients with acquired immunodeficiency syndrome (AIDS). Management involves a...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric radiology 1998-08, Vol.28 (8), p.627-629
Main Authors: NOBLE, C. B, KLEIN, L. T, STAIMAN, V. R, NEU, N, HENSLE, T. W, BERDON, W. E
Format: Article
Language:English
Subjects:
Acquired immune deficiency syndrome
Adolescent
Biological and medical sciences
Crystallization
Drug toxicity and drugs side effects treatment
HIV Infections - drug therapy
HIV Protease Inhibitors - adverse effects
HIV Protease Inhibitors - therapeutic use
Human immunodeficiency virus
Humans
Indinavir - adverse effects
Indinavir - therapeutic use
Male
Medical sciences
Pharmacology. Drug treatments
Radiography
Toxicity: urogenital system
Ureteral Calculi - chemically induced
Ureteral Calculi - complications
Ureteral Calculi - diagnostic imaging
Ureteral Obstruction - diagnostic imaging
Ureteral Obstruction - etiology
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Indinavir sulfate is a protease inhibitor used in the treatment of the human immunodeficiency virus (HIV). This case report describes the radiographic and urologic manifestations of indinavir urolithiasis in two pediatric patients with acquired immunodeficiency syndrome (AIDS). Management involves aggressive hydration and surgical intervention when indicated.
ISSN:0301-0449
1432-1998
DOI:10.1007/s002470050433